Yamamoto, Hirofumi

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 871

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a

Wada, H., Nagano, H., Yamamoto, H., Yang, Y., Kondo, M., Ota, H., Nakamura, M., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Liver International

Angiogenesis and VEGF in CancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 130

Mesothelial Cells Facilitate Cancer Stem like properties in spheroids of ovarian cancer cells

Shishido, A., Mori, S., Yokoyama, Y., Hamada, Y., Minami, K., Qian, Y., Wang, J., Hirose, H., Wu, X., Kawaguchi, N., et al. (2018) · Oncology Reports

Cancer Cells and MetastasisOvarian cancer diagnosis and treatment

Cited by 34

Gene expression of colorectal cancer: Preoperative genetic diagnosis using endoscopic biopsies

Komori, T., Takemasa, I., Yamasaki, M., Motoori, M., Kato, T., Kikkawa, N., Kawaguchi, N., Ikeda, M., Yamamoto, H., Sekimoto, M., et al. (2008) · International Journal of Oncology

Gene expression and cancer classificationGenetic factors in colorectal cancer

Cited by 16

A Phase II Study of Combined Chemotherapy with 5-Week Cycles of S-1 and CPT-11 plus Bevacizumab in Patients with Metastatic Colon Cancer

Mizushima, T., Ide, Y., Murata, K., Ohashi, I., Yasumasa, K., Fukunaga, M., Takemoto, H., Tamagawa, H., Hasegawa, J., Hata, T., et al. (2013) · Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 8